Cardiovascular Disease Doctors in Grapevine, TX Accepting Medicare

8 Cardiovascular Disease doctors found. Showing 1 - 8

Raul A Santos Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 W College St, Suite 680, Grapevine, TX 76051 Phone: 817-912-8400    Fax: 817-912-8410

Dr. Amyn Malik, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4100 Heritage Ave Ste 102, Grapevine, TX 76051 Phone: 469-251-0589    Fax: 817-381-3321

John Andrew Osborne, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3801 William D Tate Ave Ste 850, Grapevine, TX 76051 Phone: 817-310-3070

Dr. John W R Lawson, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 W College St, Suite 680, Grapevine, TX 76051 Phone: 817-912-8400    Fax: 817-912-8410

Dr. Paul S. Bhella, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2020 W State Highway 114 Ste 200, Grapevine, TX 76051 Phone: 179-128-4008

Dr. Vikas C. Jain, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1643 Lancaster Dr, Suite 203, Grapevine, TX 76051 Phone: 817-329-7670    Fax: 817-416-0145

Dr. Richard J. Feingold, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1643 Lancaster Dr, Suite 203, Grapevine, TX 76051 Phone: 817-329-7670    Fax: 817-416-0145

Dr. Jagadish Puppala, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1643 Lancaster Dr, Suite 203, Grapevine, TX 76051 Phone: 817-329-7670    Fax: 817-416-0145

News Archive

Health professionals may soon have new method to diagnose Parkinson's

Health professionals may soon have a new method of diagnosing Parkinson's disease, one that is noninvasive and inexpensive, and, in early testing, has proved to be effective more than 90 percent of the time.

India's patent office rejects Boehringer's application for pediatric antiretroviral

India's Patent Office in New Delhi earlier this month rejected German drug maker Boehringer Ingelheim's application for a pediatric version of the antiretroviral drug nevirapine, consequently allowing local generic pharmaceutical companies such as Aurobindo and Cipla to continue marketing low-cost versions of the medicine in the domestic market, the Business Standard reports.

Chromosome linked to colorectal cancer identified

Researchers at the Ontario Institute for Cancer Research and Cancer Care Ontario have successfully identified a specific genetic variation on chromosome 8 that is associated with colorectal cancer.

NexMed raises $2.3M through private placement

NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology , announced today that it has raised $2.3 million in a private placement of promissory notes from two accredited U.S. investors. The promissory notes, due on or before August 4, 2010, are repayable at NexMed's option in either cash or shares of unregistered common stock at prices ranging from $0.36 to $0.40 per share.

New and better understanding of blood vessel growth and angiogenesis in cancer

A new and better understanding of blood vessel growth and vascular development (angiogenesis) in cancer has been made possible by research carried out by a team of scientists from Moffitt Cancer Center, the University of Florida, Harvard University, Yale University and the Children's Hospital of Los Angeles.

Read more Medical News

› Verified 9 days ago